An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-24-064 - Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health	NOT-OD-24-146	OBSSR, NCCIH, NCI, NEI, NHLBI, NIA, NIDA, NIMH, NIMHD, NINR, OAR, ODP, ORWH	Jun 24, 2024	Sep 9, 2025	P01, P30, R01, R03, UG3/UH3, R34, U24, R41/R42, R21, R43/R44, R21/R33, R61
Notice of Special Interest (NOSI): Developing Digital Therapeutics for Substance Use Disorders	NOT-DA-22-056	NIDA	Feb 18, 2022	Dec 7, 2023	UG3/UH3

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-24-064 - Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Stay Connected

Government Sites

Web Policies and Notices

Site Map